world
health
organ
global
report
surveil
antimicrobi
resist
state
postantibiot
erain
common
infect
minor
injuri
killfar
apocalypt
fantasi
instead
real
possibl
centuri
report
make
clear
case
resist
common
bacteria
reach
alarm
level
mani
part
world
set
avail
treatment
option
remain
effect
common
infect
septemb
us
govern
issu
nation
polici
white
hous
nation
strategi
combat
antibioticresist
bacteria
set
task
forc
combat
antibioticresist
bacteria
despit
rise
antimicrobi
resist
hong
kong
mainland
china
correspond
effort
combat
huge
public
health
threat
appar
review
burden
problem
origin
transmiss
dynam
control
measur
use
data
local
mainland
china
possibl
survey
antibiot
produc
bacteria
antibiot
resist
gene
show
exist
vast
environment
pool
resist
gene
potenti
captur
amplifi
human
flora
given
correct
circumst
wonder
battl
human
use
antimicrobi
develop
resist
microb
start
soon
discoveri
sulphonamid
penicillin
penicillin
resist
rapidli
emerg
staphylococcu
aureu
penicillin
wide
use
human
communityacquir
penicillinresist
streptococcu
pneumonia
extendedspectrum
blactamas
esbl
produc
enterobacteriacea
increasingli
report
last
two
decad
methicillinresist
staphylococcu
aureu
mrsa
vancomycinresist
enterococcu
vre
becom
endem
mani
hospit
recent
emerg
carbapenemresist
acinetobact
baumannii
crab
multidrugresist
acinetobact
baumannii
carbapenemaseproduc
enterobacteriacea
cpe
report
mani
part
world
increas
persist
trend
mrsa
esblproduc
escherichia
coli
crab
carbapenemresist
pseudomona
aeruginosa
teach
hospit
hong
kong
illustr
figur
burden
antibiot
resist
seriou
mainland
china
accord
data
shanghai
bacteri
resist
surveil
project
involv
hospit
sinc
chinet
nation
bacteri
resist
surveil
project
china
involv
tertiari
hospit
univers
hospit
children
hospit
sinc
preval
mrsa
gradual
increas
less
preval
esblproduc
e
coli
increas
ctxm
genotyp
constitut
strain
esblproduc
e
coli
test
enterobacteriacea
decreas
suscept
carbapenem
also
observ
mainland
china
enterobacteriacea
isol
decreas
suscept
carbapenem
collect
teach
hospit
cpe
note
klebsiella
pneumonia
carbapenemas
found
six
isol
identifi
eight
two
strain
respect
dissemin
ctxm
carbapenemasetyp
resist
involv
expans
success
clone
acquisit
resist
plasmid
clonal
expans
main
mechan
kpc
dissemin
especi
healthcar
set
qi
et
al
report
k
pneumonia
variant
pandem
clone
domin
kpcproduc
clone
among
isol
hospit
nine
citi
cover
five
provinc
china
contrast
transmiss
plasmid
transposon
integron
main
vehicl
new
delhi
metalloblactamas
ndm
imptyp
gene
spread
commun
hospit
china
selftransmiss
plasmid
seem
common
vehicl
mediat
spread
plasmid
carri
detect
patient
epidemiolog
link
guangzhou
hunan
haifeng
dongguan
report
caus
nosocomi
outbreak
beij
hospit
plasmid
carri
ndm
also
report
india
unit
arab
emir
differ
imp
allel
occur
frequent
among
isol
china
gene
often
carri
broad
hostrang
plasmid
incn
incac
group
abil
shuttl
enterobacteriacea
p
aeruginosa
baumannii
among
nonglucos
ferment
preval
carbapenemresist
p
aeruginosa
found
proport
crab
also
increas
preval
plasmidencod
carbapenemas
among
crab
isol
china
found
imipenemresist
clinic
isol
collect
teach
hospit
moreov
baumannii
recent
report
four
differ
provinc
mainland
china
mortal
relat
multidrugresist
organ
resist
commonli
use
antibiot
pathogen
isol
invas
infect
associ
increas
morbid
mortal
communityacquir
infect
mortal
invas
pneumococc
pneumonia
significantli
associ
penicillin
minimum
inhibitori
concentr
mgl
higher
cefotaxim
minimum
inhibitori
concentr
mgl
higher
shown
cohort
case
crab
c
crpa
hong
kong
use
laboratori
data
queen
mari
hospit
surrog
marker
nondupl
isol
select
first
isol
patient
specimen
collect
blood
urin
respiratori
system
recruit
analysi
interpret
accord
clinic
laboratori
standard
institut
crpa
carbapenemresist
pseudomona
aeruginosa
control
antibiot
resist
china
vcc
cheng
et
al
unit
state
patient
pneumococ
bacteremia
mening
due
nonsuscept
antibiot
strain
increas
risk
mortal
inadequ
initi
antimicrobi
therapi
shown
independ
risk
factor
mortal
patient
esblproduc
enterobacteriacea
infect
illustr
two
retrospect
cohort
studi
involv
almost
subject
unit
state
itali
mortal
follow
bacteremia
caus
esblproduc
e
coli
significantli
higher
nonesblproduc
e
coli
regardless
whether
infect
acquir
commun
hospit
hospitalacquir
infect
patient
nonpneumon
mrsa
infect
higher
mortal
compar
patient
nonpneumon
methicillin
sensit
staphylococcu
aureu
infect
independ
sever
patient
underli
ill
addit
patient
nosocomi
mrsa
bacteremia
crude
mortal
accord
larg
cohort
patient
year
even
critic
ill
patient
mrsa
bacteremia
significantli
higher
attribut
mortal
rate
vs
inhospit
mortal
rate
vs
patient
methicillin
sensit
staphylococcu
aureu
bacteremia
accur
adjust
diseas
sever
carbapenemresist
gramneg
organ
also
carri
signific
mortal
hospit
patient
mortal
patient
crab
intens
care
unit
high
similarli
inhospit
mortal
patient
associ
carbapenemnonsuscept
klebsiella
pneumonia
e
coli
intens
care
unit
found
nationwid
multicent
studi
taiwan
nineteen
isol
gene
encod
carbapenemas
includ
verona
integronencod
metalloblactamas
vim
multidrugresist
organ
complic
clinic
treatment
increas
cost
hospit
antibiot
cost
higher
penicillinresist
pneumonia
group
compar
penicillinsuscept
pneumonia
canadian
dollar
vs
casecontrol
studi
casecontrol
analysi
israel
patient
esblproduc
enterobacteriacea
median
length
stay
bacteremia
day
case
interquartil
rang
versu
day
control
interquartil
rang
averag
hospit
cost
isra
shekel
case
versu
control
adjust
differ
group
use
multivari
analysi
esbl
product
remain
signific
predictor
increas
length
hospit
stay
increas
cost
cost
analysi
patient
nosocomi
mrsa
infect
also
show
mrsa
infect
independ
associ
higher
hospit
cost
median
us
vs
us
higher
postdischarg
healthcareassoci
financi
cost
median
us
vs
us
match
casecontrol
studi
endem
area
impact
carbapenem
resist
cost
outcom
among
patient
p
aeruginosa
baumannii
infect
also
studi
compar
patient
infect
imipenemsuscept
p
aeruginosa
patient
infect
imipenemresist
p
aeruginosa
longer
hospit
day
vs
day
greater
hospit
cost
us
vs
us
averag
total
cost
hospit
among
patient
crab
significantli
higher
among
patient
carbapenemsuscept
baumannii
multivari
analysi
adjust
cost
us
vs
us
cost
medic
intens
care
unit
closur
due
outbreak
crab
hospit
estim
cost
wast
elimin
clean
procedur
cost
drug
nonclean
equip
destruct
approxim
estim
direct
cost
intens
care
unit
closur
increas
trend
antibiot
consumpt
anim
husbandri
associ
spread
antimicrobi
resist
earlier
studi
intestin
flora
farm
personnel
chang
use
tetracyclinesuppl
feed
chicken
farm
expect
intestin
flora
chicken
consist
almost
entir
tetracyclineresist
organ
within
one
week
start
tetracyclinesuppl
feed
furthermor
weekli
fecal
sampl
farm
dweller
convert
intestin
flora
consist
greater
tetracyclineresist
bacteria
within
month
select
pressur
tetracyclinesuppl
feed
chicken
appear
extend
human
contact
chicken
feed
result
chang
predomin
tetracyclineresist
intestin
flora
occurr
acquir
resist
antimicrobi
use
growth
promot
among
bacteria
isol
swine
cattl
poultri
demonstr
denmark
octob
septemb
fact
clear
signific
increas
amount
resist
gene
fecal
metagenom
spanish
danish
american
subject
antibiot
approv
anim
use
food
drug
administr
unit
state
antibiot
histor
use
market
accord
survey
china
produc
consum
largest
quantiti
antimicrobi
countri
estim
annual
antimicrobi
product
china
million
kg
use
livestock
industri
recent
analysi
antimicrobi
consumpt
unit
state
estim
annual
antibiot
use
livestock
million
kg
follow
human
million
kg
aquacultur
million
kg
pet
million
kg
crop
million
kg
approxim
antibiot
consum
agricultur
aquacultur
use
antibiot
human
also
correl
increas
isol
multidrug
resist
organ
mdro
associ
crab
infect
hospit
antimicrobi
usag
assess
tertiari
care
hospit
northeast
china
found
rate
crab
increas
significantli
quarterli
use
carbapenem
class
antibiot
correl
strongli
increas
quarterli
isol
crab
similarli
signific
increas
usag
carbapenem
strongli
correl
isol
imipenemand
meropenemresist
p
aeruginosa
high
incid
mdro
like
relat
inappropri
use
antimicrobi
agent
mainland
china
studi
conduct
mainland
chinath
first
kindexamin
prescript
written
commun
health
institut
citi
across
china
reveal
substanti
overprescrib
includ
twice
mani
prescript
antibiot
recommend
anoth
observ
studi
conduct
sichuan
provinc
agricultur
econom
develop
provinc
western
china
collect
analyz
total
prescript
township
health
center
approxim
prescript
contain
antibiot
contain
control
antibiot
resist
china
vcc
cheng
et
al
two
type
antibiot
irrat
prescript
practic
due
pursuit
maxim
monetari
profit
township
health
center
well
lack
medic
knowledg
ration
prescript
practic
among
rural
doctor
lack
diagnost
medic
laboratori
servic
township
health
center
fact
antimicrobi
abus
china
driven
patient
demand
mainli
supplydriven
phenomenon
illustr
audit
studi
studi
pair
simul
patient
ident
flulik
symptom
visit
physician
simul
patient
ask
question
show
knowledg
appropri
antibiot
use
wherea
patient
b
said
noth
beyond
describ
symptom
interest
note
patient
display
knowledg
appropri
antibiot
use
prescrib
fewer
antibiot
nondiscretionari
use
antibiot
agricultur
human
medicin
led
discharg
mani
residu
antimicrobi
compound
deriv
sewag
system
consid
emerg
environment
nich
dissemin
antimicrobi
resist
gene
coastal
water
bohai
bay
northern
china
investig
presenc
antibiot
six
differ
class
antibiot
level
north
bohai
bay
gener
higher
south
highlight
remark
effect
highdens
aquacultur
activ
exposur
environ
antimicrobi
antibiot
level
found
six
river
flow
bohai
bay
gener
higher
bohai
bay
reflect
import
river
discharg
sourc
antibiot
eastern
china
occurr
dissip
select
antibiot
includ
tetracyclin
sulfonamid
macrolid
fluoroquinolon
chloramphenicol
investig
two
swine
wastewat
treatment
system
anticip
highest
contamin
tetracyclin
oxytetracyclin
chlortetracyclin
doxycyclin
sulfadiazin
note
sampl
test
maximum
concentr
reach
mgl
respect
southern
china
fluoroquinolon
ciprofloxacin
norfloxacin
ofloxacin
macrolid
dehydroerythromycin
roxithromycin
clarithromycin
sulfonamid
sulfamethoxazol
sulfamethazin
trimethoprim
ubiquit
wastewat
fluoroquinolon
norfloxacin
abundantli
detect
antibiot
raw
sewag
maximum
concentr
mgl
median
percentag
sulfonamid
macrolid
remain
final
effluent
treatment
sewag
treatment
plant
urban
region
southern
china
sulfamethoxazol
frequent
detect
antibiot
residu
guangzhou
section
major
pearl
river
maximum
concentr
sulfamethoxazol
reach
mgl
raw
wastewat
largescal
sewag
treatment
plant
guangzhou
hong
kong
studi
reveal
cephalexin
amoxicillin
ofloxacin
erythromycin
ubiquit
seawat
throughout
victoria
harbor
indic
continu
discharg
environ
sewag
treatment
plant
hong
kong
cephalexin
ofloxacin
erythromycin
found
concentr
mgl
influent
respect
degre
contamin
compar
level
report
urban
region
mainland
china
expect
residu
antibiot
wastewat
select
enrich
resist
gene
environment
bacteria
turn
could
eventu
enter
food
chain
via
food
anim
agricultur
produc
close
contact
soil
water
inevit
contamin
anim
human
sewag
china
occurr
divers
mani
differ
transmiss
gene
confer
fluoroquinolon
resist
qnra
qnrd
oqxa
aac
ibcr
esbl
coexist
differ
isol
serovar
nontyphoid
salmonella
foodproduc
anim
presenc
mdro
foodproduc
anim
may
carri
risk
global
dissemin
antibiot
resist
hong
kong
longitudin
studi
confirm
endem
presenc
esblproduc
e
coli
isol
major
foodproduc
anim
chicken
pig
cattl
increas
preval
approxim
seven
live
chicken
eight
pig
five
cattl
found
carri
bacteria
figur
among
esblproduc
isol
carri
anim
coresist
class
antimicrobi
tetracyclin
aminoglycosid
sulphonamid
fluoroquinolon
wide
use
anim
feed
veterinari
treatment
also
detect
molecular
epidemiolog
investig
demonstr
predomin
resist
determin
associ
resist
expandedspectrum
cephalosporin
bla
ctxm
aminoglycosid
sulphonamid
sul
level
gene
allel
integron
cassett
plasmid
vehicl
anim
isol
ident
highli
similar
carri
asymptomat
human
clinic
e
coli
isol
hong
kong
light
associ
antibiot
use
farm
subsequ
identif
mdro
food
anim
food
product
control
antibiot
use
farm
becom
one
import
upstream
control
measur
figur
restrict
antibiot
use
growth
promot
farm
first
introduc
sweden
swedish
farmer
support
ban
consum
confid
meat
safeti
drop
public
learn
ton
per
year
antibiot
use
sweden
food
anim
product
similarli
consum
concern
regard
antimicrobi
resist
farmer
denmark
voluntarili
stop
antimicrobi
use
growth
promot
govern
ban
use
avoparcin
virginiamycin
respect
avoparcin
ban
follow
decreas
occurr
glycopeptideresist
e
faecium
broiler
mani
european
countri
demonstr
mark
decreas
antimicrobi
resist
restrict
antimicrobi
use
food
anim
consequ
use
certain
antimicrobi
agent
avoparcin
tylosin
spiramycin
bacitracin
virginiamycin
anim
growth
promot
ban
european
union
health
ministri
european
union
subsequ
agre
discontinu
use
antimicrobi
growth
promot
urgenc
perform
intens
surveil
type
amount
indic
use
antibiot
farm
data
must
transpar
public
usag
must
audit
use
antibiot
growth
promot
must
ban
tabl
anim
health
better
serv
better
biosecur
antimicrobi
abus
wastewat
sewag
treatment
plant
design
improv
qualiti
water
discharg
urban
industri
agricultur
facil
natur
environ
howev
treatment
process
wastewat
treatment
plant
erad
mdro
water
sampl
collect
cultur
weekli
period
site
throughout
wastewat
network
citi
franc
detect
amount
esblproduc
e
coli
although
quantiti
esblproduc
e
coli
lower
treat
water
untreat
water
vs
coloni
form
unit
cfu
ml
proport
esblproduc
e
coli
significantli
higher
effluent
influent
vs
similarli
anoth
studi
evalu
risk
dissemin
antibioticresist
p
aeruginosa
hospit
environ
via
wastewat
network
studi
design
water
treatment
effect
remov
p
aeruginosa
effluent
decreas
proport
antibioticresist
strain
therefor
treat
water
sewag
sludg
still
pose
risk
environment
contamin
studi
focus
methodolog
elimin
mdro
effluent
wastewat
treatment
plant
antibiot
consumpt
commun
strongli
associ
increas
antibiot
resist
recent
publish
metaanalysi
relationship
antibiot
resist
pattern
bacteria
circul
commun
consumpt
antibiot
commun
shown
increas
antibiot
produc
greater
antimicrobi
resist
level
individu
patient
may
also
produc
greater
resist
commun
whole
antibiot
consumpt
increas
billion
standard
unit
billion
standard
unit
accord
drug
sale
data
countri
brazil
russia
india
china
south
africa
account
increas
educ
physician
privat
care
import
strategi
control
antibiot
use
tabl
studi
use
mix
qualit
quantit
evalu
random
control
communitywid
educ
intervent
massachusett
commun
physician
intervent
commun
receiv
local
endors
guidelin
group
educ
session
biweekli
newslett
physician
intervent
arm
report
decreas
antibiot
prescript
compar
control
physician
vs
moreov
patient
parent
educ
aim
enhanc
knowledg
awar
antibiot
resist
appropri
antibiot
use
equal
import
addit
tradit
educ
target
physician
patient
parent
clear
health
messag
dissemin
gener
public
readytoeat
undercook
food
item
avoid
especi
antibiot
therapi
studi
investig
figur
transmiss
cycl
antibiot
resist
human
environ
control
antibiot
resist
china
vcc
cheng
et
al
influx
enterococc
antibiot
resist
virul
gene
readytoeat
food
human
digest
tract
estim
influx
tet
gene
human
digest
tract
gene
copi
per
meal
chicken
salad
influx
antibiot
resist
gene
associ
readytoeat
food
commonli
consum
may
play
role
acquisit
antibioticresist
bacteria
human
digest
tract
similarli
bacteria
carri
antibiot
resist
gene
also
found
carrot
organ
nonorgan
salad
veget
thu
uncook
veget
anoth
potenti
sourc
highli
resist
opportunist
pathogen
french
survey
antibioticresist
bacteria
type
organ
convent
fruit
veget
irrespect
mode
product
carri
bacteria
produc
extendedspectrum
blactamas
henc
organ
convent
fruit
well
veget
may
constitut
signific
sourc
resist
bacteria
resist
gene
still
rare
carbapenemaseproduc
bacteria
report
foodproduc
anim
environ
e
coli
produc
carbapenemas
isol
pig
farm
salmonella
enterica
subsp
enterica
produc
carbapenemas
isol
livestock
farm
germani
nine
cattl
sampl
franc
carri
carbapenemaseproduc
lwoffii
bla
gene
identif
bla
carri
strain
lwoffii
swab
sampl
chicken
collect
anim
farm
one
slaughterhous
eastern
china
reveal
potenti
bla
transmiss
anim
human
survey
gramneg
bacteria
pig
chicken
duck
conduct
southern
china
guangdong
provinc
novemb
may
sampl
collect
five
commerci
pig
farm
three
commerci
chicken
farm
one
duck
farm
one
singl
baumannii
isol
lung
sampl
pig
pneumonia
sepsi
posit
bla
although
anecdot
report
carbapenemas
routin
test
bacteri
isol
nonhuman
sourc
mani
veterinari
laboratori
current
adopt
method
recommend
screen
cpe
hong
kong
target
test
fecal
e
coli
isol
nontherapeut
use
antibiot
growth
promot
ban
increas
farm
product
improv
biosecur
audit
appropri
antibiot
treatment
sick
anim
control
outbreak
among
anim
surveil
sewag
discharg
antimicrobi
residu
resist
gene
research
develop
effect
method
elimin
mdro
wastewat
treatment
plant
discharg
environ
medic
profession
provis
uptod
antibiot
prescript
guidelin
physician
educ
reduc
unnecessari
antibiot
prescript
outpati
clinic
regular
audit
antibiot
usag
commun
health
warn
antibiot
prescript
bag
emphas
import
hand
food
hygien
antibiot
treatment
public
educ
appropri
indic
antibiot
elimin
misconcept
antibiot
use
help
reduc
irrat
demand
antibiot
patient
educ
avoid
ingest
uncook
undercook
food
item
especi
antibiot
therapi
educ
kitchen
hygien
prevent
cross
contamin
food
promot
hand
hygien
practic
use
alcoholbas
hand
rub
especi
antibiot
therapi
antimicrobi
stewardship
program
aim
reduc
antibiot
select
pressur
reduc
unnecessari
antibiot
use
proactiv
surveil
cultur
high
risk
patient
earli
identif
patient
asymptomat
colon
mdro
contact
precaut
singl
room
isol
patient
colon
infect
mdro
decolon
mdro
applic
environment
decontamin
frequent
mutual
touch
surfac
item
healthcar
worker
patient
visitor
provis
pamphlet
hospit
patient
visitor
enhanc
complianc
infect
control
measur
person
protect
nosocomi
acquisit
mdro
hand
hygien
alcoholbas
hand
rub
hand
visibl
soil
practic
entri
exit
control
implement
directli
observ
hand
hygien
consciou
patient
oral
hygien
ingest
meal
medic
use
toilet
hospitalbas
measur
incorpor
infect
control
complianc
core
compon
human
resourc
polici
health
care
institut
employ
independ
audit
team
monitor
infect
control
perform
includ
hand
hygien
complianc
environment
cleanli
healthcar
institut
invest
new
technolog
electron
immedi
feedback
devic
monitor
increas
awar
practic
hand
hygien
nationalregionalbas
measur
format
legisl
illeg
use
antibiot
growth
promot
farm
nation
polici
mandat
surveil
mdro
anim
human
environ
activ
surveil
audit
antimicrobi
consumpt
hospit
commun
surveil
number
hospitalacquir
mdro
per
patientday
across
differ
hospit
regular
report
public
regular
health
promot
campaign
commun
promot
awar
appropri
antibiot
use
food
person
hygien
among
popul
format
antimicrobi
resist
work
group
local
govern
overse
surveil
data
measur
well
set
goal
initi
continu
control
antibiot
resist
commun
whole
control
antibiot
resist
china
vcc
cheng
et
al
anim
chicken
pig
cattl
cat
dog
septemb
august
reveal
two
isol
nonsuscept
ertapenem
ie
disc
inhibit
diamet
mm
two
isol
polymeras
chain
reactionneg
kpc
ndm
vim
imp
oxatyp
carbapenemas
gene
pl
ho
et
al
unpublish
data
presenc
mdro
food
anim
food
item
alert
gener
public
compli
good
hand
hygien
practic
avoid
eat
raw
undercook
food
especi
receiv
antimicrobi
therapi
antibiot
resist
anim
may
transfer
human
direct
contact
anim
contamin
food
water
also
indirect
contact
contamin
environ
given
abund
antimicrobialresist
e
coli
food
anim
meat
product
would
inform
assess
risk
human
exposur
summer
camp
outbreak
foodborn
salmonella
gastroenter
two
multiresist
e
coli
strain
found
along
enterica
nine
investig
individu
rais
possibl
contamin
food
water
vehicl
simultan
dissemin
salmonella
resist
e
coli
camper
investig
spain
evalu
possibl
investig
stool
sampl
peopl
involv
anoth
episod
acut
gastroenter
outbreak
outbreakrel
food
handler
outbreak
one
investig
subject
carri
one
esblproduc
bacteria
outbreak
two
diner
found
share
esblproduc
bacteria
four
strain
ident
bacteria
isol
food
handler
use
mathemat
model
depoort
et
al
assess
risk
human
exposur
antimicrobialresist
e
coli
consumpt
broiler
meat
belgium
e
coli
strain
isol
live
broiler
resist
thirdgener
cephalosporin
use
baselin
data
estim
probabl
exposur
cfu
resist
e
coli
consumpt
meal
contain
chicken
meat
calcul
risk
mainli
attribut
crosscontamin
kitchen
rather
undercook
given
much
higher
frequenc
esblproduc
enterobacteriacea
live
poultri
hong
kong
model
predict
chanc
consum
resist
bacteria
serv
broiler
meat
could
high
exposur
level
cfu
recent
studi
scandinavia
return
travel
fecal
colon
esblproduc
enterobacteriacea
risk
higher
among
travel
south
asia
take
antimicrobi
theori
ingest
plasmid
dna
fragment
contain
resist
determin
might
also
pose
risk
human
microbiota
may
acquir
resist
gene
transform
howev
risk
resist
emerg
rout
exposur
seem
exceedingli
low
least
member
gut
microbiota
natur
compet
free
dna
e
coli
klebsiella
spp
anim
model
use
acinetobact
baylyi
compet
free
dna
extens
ingest
plasmid
dna
mg
per
day
encod
resist
gene
produc
antibioticresist
transform
among
aerob
microbiota
detect
limit
transform
per
cultur
bacteria
content
within
rodent
gastrointestin
tract
may
shield
adsorb
plasmid
dna
prevent
exposur
foodderiv
dna
fragment
compet
bacteria
observ
lack
dna
uptak
gut
bacteria
might
also
relat
lack
express
bacteri
compet
insid
gut
insuffici
free
dna
concentr
suboptim
biochem
condit
transform
use
assay
method
sensit
enough
detect
low
level
transform
find
suggest
ingest
plasmid
dna
lead
fecal
colon
thu
eat
food
cook
heat
immedi
consumpt
good
attent
prevent
crosscontamin
kitchen
may
help
safeguard
intestin
colon
foodacquir
mdro
determin
confer
resist
sever
differ
class
antibiot
often
found
togeth
mobil
genet
element
plasmid
transposon
switch
differ
class
antibiot
may
reduc
antibiot
select
pressur
therefor
import
reduc
overal
use
antibiot
human
anim
proactiv
infect
control
measur
must
place
prevent
nosocomi
dissemin
mdro
especi
context
ongo
complic
mdro
transmiss
dynam
hospit
commun
figur
mdro
yet
endem
hospit
proactiv
surveil
cultur
allow
earli
recognit
patient
asymptomat
colon
mdro
tabl
hong
kong
adopt
screen
model
previous
describ
repres
histori
hospit
outsid
hong
kong
medic
tourism
repres
histori
receiv
surgic
oper
outsid
hong
kong
within
preced
month
admiss
especi
area
mainland
china
enterobacteriacea
report
howev
travel
histori
alon
without
contact
medic
care
may
becom
potenti
risk
factor
acquisit
mdro
bacteria
found
water
sampl
collect
river
water
treat
drink
water
water
sampl
pool
sewag
comprehens
hospit
beij
identifi
two
drinkingwat
sampl
seepag
sampl
new
delhi
india
acquisit
cpe
two
one
recent
document
three
healthi
travel
return
india
without
healthcar
contact
patient
histori
admiss
local
hospit
preced
three
month
also
includ
activ
surveil
educ
pamphlet
deliv
patient
upon
admiss
remind
import
infect
control
practic
figur
rectal
swab
collect
patient
fulfil
aforement
criteria
identifi
patient
asymptomat
gastrointestin
carriag
vre
crab
cpe
yet
endem
hong
kong
carriag
mdro
may
unmask
subsequ
prolong
antibiot
use
hospit
safeti
net
screen
patient
hospit
day
well
inpati
stool
sent
clostridium
difficil
cytotoxin
cultur
implement
previous
describ
enhanc
detect
newli
diagnos
patient
carri
vre
cpe
bedsid
assess
carri
infect
control
team
coordin
ascertain
strict
contact
precaut
isol
patient
singl
room
implement
extens
contact
trace
secondari
case
perform
index
vre
cpe
patient
hospit
h
open
cubicl
durat
extens
contact
trace
includ
entir
durat
hospit
index
patient
cover
potenti
expos
patient
immedi
rectal
swab
screen
conduct
potenti
expos
patient
still
hospit
within
hospit
discharg
expos
patient
label
vre
cpe
contact
patient
hospit
comput
system
infect
control
nurs
screen
vre
cpe
perform
upon
hospit
readmiss
expos
patient
discharg
residenti
care
home
elderli
site
visit
collect
rectal
swab
perform
commun
geriatr
assess
team
within
one
week
secondari
vreor
creposit
case
confirm
residenti
care
home
elderli
resid
residenti
care
home
elderli
screen
asymptomat
gastrointestin
carriag
vre
cpe
fact
vigor
screen
isol
mrsa
perform
scandinavian
dutch
late
preval
mrsa
remain
less
admiss
screen
preval
us
part
europ
much
higher
experi
strongli
support
concept
proactiv
screen
isol
decolon
also
call
search
kill
strategi
mandatori
surveil
also
use
even
endem
set
mrsa
bacteremia
england
reduc
less
case
per
year
addit
activ
surveil
play
import
role
control
hospitalwid
outbreak
carbapenemresist
k
pneumonia
infect
israel
day
contact
precaut
ad
result
activ
surveil
howev
infect
control
measur
limit
institut
nationwid
intervent
launch
contain
mdro
illustr
contain
countrywid
outbreak
carbapenemresist
k
pneumonia
isra
hospit
via
nation
implement
intervent
monthli
incid
nosocomi
carbapenemresist
k
pneumonia
significantli
reduc
case
per
patientday
march
case
per
patientday
may
hand
hygien
alway
consid
critic
compon
infect
control
practic
promot
five
moment
recommendationnam
patient
contact
asept
task
bodi
fluid
exposur
risk
patient
contact
contact
patient
surroundingsi
key
measur
reduc
risk
nosocomi
transmiss
mdro
complianc
often
limit
first
four
moment
moment
therefor
mdro
easili
transmit
via
contact
mutual
touch
item
healthcar
worker
consciou
patient
visitor
institut
environ
figur
although
hand
hygien
monitor
demonstr
complianc
center
manual
observ
hand
hygien
practic
may
overestim
due
hawthorn
effect
hand
hygien
complianc
continu
unobtrus
monitor
electron
monitor
system
overal
complianc
found
less
consist
previou
find
concept
infect
control
simpl
complianc
difficult
introduct
directli
observ
control
antibiot
resist
china
vcc
cheng
et
al
hand
hygien
clinic
set
may
better
option
design
healthcar
assist
nurs
deliv
alcoholbas
hand
rub
consciou
patient
healthcar
worker
everi
h
practic
appear
use
prevent
nosocomi
outbreak
due
epidemiolog
import
virus
mdro
set
mani
patient
healthcar
worker
clinic
area
hand
hygien
practic
consciou
patient
equal
import
directli
observ
hand
hygien
patient
promot
new
core
infect
control
compon
alcoholbas
hand
rub
deliv
consciou
patient
meal
medic
addit
alcohol
foam
hand
rub
also
made
avail
patient
bathroom
patient
encourag
disinfect
toilet
seat
prior
use
clean
hand
use
toilet
figur
slogan
entri
exit
control
use
campaign
highlight
key
measur
break
fecalor
transmiss
vre
cpe
hospit
strateg
measur
entri
exit
control
shown
effect
control
endem
multidrugresist
acinetobact
baumannii
local
addit
educ
pamphlet
precautionari
measur
antimicrobi
therapi
distribut
admiss
offic
inpati
pharmaci
outpati
prescrib
antibiot
figur
control
endem
mdro
mrsa
antimicrobi
stewardship
program
reduc
antibiot
select
pressur
defec
use
bedpan
pleas
use
wet
tissu
wipe
hand
ask
ward
staff
provid
alcohol
handrub
disinfect
hand
defec
wash
hand
soap
water
disinfect
hand
alcohol
handrub
urin
usual
wash
hand
soap
water
take
antibiot
necessari
cure
infect
antibiot
also
kill
normal
bacteria
bodi
predispos
acquir
resist
bacteria
figur
educ
pamphlet
selfprotect
antibiot
therapi
control
antibiot
resist
china
vcc
cheng
et
al
environment
disinfect
focu
frequent
touch
area
enforc
mrsaposit
case
best
nurs
isol
room
howev
limit
number
isol
facil
mani
hospit
innov
measur
implement
priorit
util
isol
room
studi
previous
found
higher
transmiss
mrsa
certain
spa
type
use
broadspectrum
antibiot
could
increas
bacteri
load
lead
increas
risk
environment
contamin
patient
asymptomat
colon
mrsa
therefor
singl
room
isol
reserv
mrsa
patient
aforement
characterist
mrsaposit
patient
implement
chlorhexidin
glucon
daili
bath
addit
hand
hygien
campaign
contact
precaut
open
cubicl
could
limit
nosocomi
transmiss
mrsa
highli
endem
set
decolon
mrsa
may
reduc
burden
mrsa
use
regimen
nasal
mupirocin
ointment
chlorhexidin
mouth
rins
wholebodi
wash
didecyldimonium
chlorid
gave
erad
rate
median
followup
month
compar
spontan
clearanc
rate
nondecolon
group
recent
studi
involv
adult
intens
care
unit
suggest
univers
decolon
may
effect
target
decolon
screen
isol
reduc
rate
clinic
mrsa
isol
bloodstream
infect
due
pathogen
contrast
mrsa
decolon
vre
decolon
controversi
bacitracincontain
regimen
given
oral
via
gastrostomi
tube
day
report
although
overal
observ
rate
vre
clearanc
found
patient
treat
bacitracincontain
regimen
longterm
followup
show
persist
decolon
vre
observ
patient
three
week
posttreat
use
lactobacillu
rhamnosu
gg
lactobacillu
rhamnosu
attempt
decolon
vre
patient
result
variabl
failur
regimen
like
relat
lack
effect
decolon
regimen
prolong
asymptomat
carriag
vre
gastrointestin
tract
perpetu
endem
vre
healthcar
set
recent
introduc
novel
regimen
vre
decolon
sustain
decolon
gastrointestin
carriag
vre
achiev
combin
environment
disinfect
patient
isol
bowel
prepar
washout
fecal
bacteri
popul
use
polyethylen
glycol
fiveday
cours
oral
absorb
linezolid
nonabsorb
daptomycin
suppress
remain
vre
subsequ
oral
lactobacillu
rhamnosu
gg
reinstat
colon
resist
strategi
studi
set
low
vre
endem
limit
isol
facil
residenti
care
home
elderli
consid
potenti
reservoir
mdro
mani
part
world
hong
kong
resid
residenti
care
home
elderli
account
estim
acut
hospit
admiss
recent
preval
studi
rate
asymptomat
nasal
mrsa
carriag
among
residenti
care
home
elderli
hong
kong
transmiss
mrsa
within
residenti
care
home
elderli
found
three
time
higher
hospit
therefor
infect
control
measur
must
implement
residenti
care
home
elderli
order
reduc
burden
mrsa
carrier
healthcar
set
summari
control
antimicrobi
resist
hong
kong
mainland
china
depend
intens
surveil
farm
wastewat
treatment
plant
outpati
clinic
healthcar
institut
paramet
includ
antimicrobi
consumpt
environment
contamin
antimicrobi
resist
monitor
appropri
follow
action
antimicrobi
use
anim
must
ban
biosecur
measur
farm
strengthen
sewag
wastewat
treatment
improv
prevent
resist
bacteria
get
water
soil
fertil
antimicrobi
treatment
healthcar
set
given
accord
evidencebas
guidelin
regular
audit
place
reduc
inappropri
usag
durat
antibiot
treatment
heighten
public
awar
combat
antimicrobi
resist
complianc
food
person
hygien
import
decreas
acquisit
antimicrobi
resist
especi
take
antibiot
educ
pamphlet
hand
patient
rel
await
hospit
admiss
drug
prescript
pharmaci
combin
proactiv
ad
test
emerg
mdro
directli
observ
hand
hygien
entri
exit
control
strategi
import
addit
measur
control
prevent
new
antimicrobi
resist
hospit
intervent
healthcar
set
region
coordin
patient
staff
visitor
often
transfer
acut
hospit
servic
convalesc
hospit
elderli
residenti
home
data
hand
hygien
complianc
broadspectrum
antibiot
consumpt
incid
newli
diagnos
hospitalacquir
mdro
regularli
releas
public
perform
individu
hospit
subject
audit
public
time
time
